Ceramide Synthase 2 Antikörper
-
- Target Alle Ceramide Synthase 2 (CERS2) Antikörper anzeigen
- Ceramide Synthase 2 (CERS2)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Ceramide Synthase 2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Immunogen
- A synthetic peptide (conjugated with KLH) corresponding to the extracellular region of human LASS2 .
- Klon
- N39
- Isotyp
- IgG2b
- Top Product
- Discover our top product CERS2 Primärantikörper
-
-
- Applikationshinweise
- WB (1:500-1000). Other applications have not been tested. The optimal dilutions should be determined by end user.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- TBS (pH7.4), 0.5% BSA, 40% Glycerol and 0.05% Sodium Azide.
- Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C after thawing (1 week). Aliquot and store at -20 °C for long term (at least one year). Avoid repeated freeze and thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- Ceramide Synthase 2 (CERS2)
- Andere Bezeichnung
- LAG1 longevity assurance homolog 2, LASS2 (CERS2 Produkte)
- Hintergrund
- Lass2 (LAG1 longevity assurance homolog 2) is a protein that in humans is encoded by the LASS2 gene. It has sequence similarity to yeast longevity assurance gene 1. And it is highly expressed in liver and kidney, which is very different from the expression of the previously identified human LAG1 homologue LAG1Hs-1. Mutation or overexpression of the related gene in yeast has been shown to alter yeast lifespan. LASS2 protein was able to inhibit the colony formation of human hepatoma cells in vitro, and it also plays a role in the regulation of cell growth.
-